AAM
IMGN

Alpine Associates Management’s Immunogen Inc IMGN Stock Holding History

Alpine Associates Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,761,300
Closed -$52.2M – 56
2023
Q4 		$52.2M Buy
+1,761,300
New +$35.1M 2.68% 13

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Alpine Associates Management's IMGN Position: Q1 2024 in Review

Alpine Associates Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,761,300 shares — an estimated $52.2M sold.

Alpine Associates Management first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $52.2M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Alpine Associates Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Alpine Associates Management sold 1,761,300 Immunogen Inc shares in Q1 2024, an estimated $52.2M.
  • Alpine Associates Management first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Alpine Associates Management's Immunogen Inc position peaked at $52.2M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Alpine Associates Management's 13F filing for Q1 2024, filed 9 May 2024.